IRLAB granted additional patent for its drug candidate pirepemat expanding the patent protection in the US
IRLAB granted additional patent for its drug candidate pirepemat expanding the patent protection in the US
Gothenburg, Sweden, September 18, 2024 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that a new patent has been granted in the US covering a salt of the drug candidate pirepemat. The patent covers the active pharmaceutical ingredient used in the ongoing clinical development of pirepemat.
“The patent granted today is an important addition to IRLAB’s already strong patent portfolio for pirepemat. The patent portfolio allows for a potential market exclusivity reaching into the early 2040s in most of the key geographies. The granting of this new patent brings a substantial increase in commercial value of the pirepemat program, ” said Kristina Torfgård, CEO of IRLAB.
Pirepemat has the potential to become the first treatment in a new class of drugs designed to reduce falls, and thus fall injuries, in people living with Parkinson’s disease.
The latest patent, covering the salt of the drug used in the ongoing clinical development, has previously been granted in Europe, Japan and China, predicted to expire in 2038. With the awarded patent term adjustment (PTA) and potential grant of patent term extension (PTE), exclusivity in the US will reach into the early 2040s.
Pirepemat has previously been granted composition of matter patents, providing pirepemat exclusivity in all the major markets such as China, Europe, Japan, and the US. Furthermore, a patent directed to the process for the preparation of pirepemat has recently been granted in the US.
Latest Posts
- Nayax Launches AI-Powered Product Discovery for Retailers
May 29, 2026 | AI & ML, Breaking News, World - CropLife International Report Reveals Challenges in Developing Modern Crop Protection Products
May 29, 2026 | Breaking News, Business, World - Doda: TLR News Facebook Page Geo-Blocked in India, Authorities Yet to Release Any Information
May 29, 2026 | Breaking News, Doda, Jammu Kashmir - Delhi Court Issues Notice to CM Himanta Biswa Sarma Regarding Provocative Miya Remarks
May 29, 2026 | Breaking News, India, Politics - Siddaramaiah Resigns as Karnataka CM; Shiva Kumar Likely to be Next Chief Minister
May 29, 2026 | Breaking News, India, Politics - Iran-US War Key Developments: US Sanctions Persian Gulf Strait Authority, Iran Attacks US Naval Base, Trump Threatens
May 28, 2026 | Breaking News, Politics, World - India and China Advance Constructive and Forward-Looking Discussions on Border Situation in Ladakh
May 28, 2026 | Breaking News, India, World - India Makes Royal Entry, Approves First 10-Car Hydrogen-Powered Trainset
May 28, 2026 | Breaking News, Climate & Environment, India - Possible Ice Signals Detected by ISRO Beneath Moon’s Surface Using Chandrayaan-2 Data
May 28, 2026 | Breaking News, Tech, Technology - US Delegation To Visit India From June 1-4 For Trade Pact Talks; A Push to India-US Bilateral Trade
May 27, 2026 | Breaking News, India, World